» Articles » PMID: 18404149

High-throughput Kinase Profiling As a Platform for Drug Discovery

Overview
Specialty Pharmacology
Date 2008 Apr 12
PMID 18404149
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

To fully exploit the potential of kinases as drug targets, novel strategies for the efficient discovery of inhibitors are required. In contrast to the traditional, linear process of inhibitor discovery, high-throughput kinase profiling enables a parallel approach by interrogating compounds against hundreds of targets in a single screen. Compound potency and selectivity are determined simultaneously, providing a choice of targets to pursue that is guided by the quality of lead compounds available, rather than by target biology alone.

Citing Articles

Ligand discovery by activity-based protein profiling.

Niphakis M, Cravatt B Cell Chem Biol. 2024; 31(9):1636-1651.

PMID: 39303700 PMC: 11662599. DOI: 10.1016/j.chembiol.2024.08.006.


Large-scale comparison of machine learning methods for profiling prediction of kinase inhibitors.

Wu J, Chen Y, Wu J, Zhao D, Huang J, Lin M J Cheminform. 2024; 16(1):13.

PMID: 38291477 PMC: 10829268. DOI: 10.1186/s13321-023-00799-5.


Structure-based development of potent and selective type-II kinase inhibitors of RIPK1.

Qin Y, Li D, Qi C, Xiang H, Meng H, Liu J Acta Pharm Sin B. 2024; 14(1):319-334.

PMID: 38261830 PMC: 10793102. DOI: 10.1016/j.apsb.2023.10.021.


LIMS-Kinase provides sensitive and generalizable label-free measurement of kinase activity using mass spectrometry.

Meyer C, McCoy M, Li L, Posner B, Westover K Cell Rep Phys Sci. 2024; 4(10).

PMID: 38213501 PMC: 10783653. DOI: 10.1016/j.xcrp.2023.101599.


KD025 Is a Casein Kinase 2 Inhibitor That Protects Against Glucolipotoxicity in β-Cells.

Devkota R, Small J, Carbone K, Glass M, Vetere A, Wagner B Diabetes. 2024; 73(4):585-591.

PMID: 38211571 PMC: 10958584. DOI: 10.2337/db23-0506.